(Total Views: 941)
Posted On: 11/02/2020 9:47:28 PM
Post# of 148903
NeuroRX Submits Request for Emergency Use Authorization for RLF-100 in Treatment of COVID-19 Patients with Respiratory Failure & No Other Recourse
Did they meet Primary Endpoint in their Phase III s/c Clinical Trial.
If not, what is the basis for their "Request"
Shouldn't Cytodyn Request EUA for Leronlimab m/m? For s/c.
For eIND for s/c?
Did they meet Primary Endpoint in their Phase III s/c Clinical Trial.
If not, what is the basis for their "Request"
Shouldn't Cytodyn Request EUA for Leronlimab m/m? For s/c.
For eIND for s/c?
(2)
(0)Scroll down for more posts ▼
